If you’ve used CBD for these reasons above, you might enjoy peace of mind knowing scientists have found the possible benefits you’ve known all along. . . . → Read More: What Science Has to Say About CBD
|
|||||
If you’ve used CBD for these reasons above, you might enjoy peace of mind knowing scientists have found the possible benefits you’ve known all along. . . . → Read More: What Science Has to Say About CBD A clinical trial is underway testing a new type of therapy its developer says addresses damage to nerve cells associated with a number of neurological disorders. . . . → Read More: Trial Begins for Multi-Neurological Disease Therapy A health research foundation grant is funding development of a vaccine protecting against typhoid fever, given in a patch from from a spring-loaded device. . . . → Read More: Grant Funds Typhoid Vaccine Patch Development The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19. . . . → Read More: HHS Directs $100M for Covid-19 Venture Investments A company developing a drug delivery process with treatments activated by ultrasound received an option to license a key technology from its founders’ university labs. . . . → Read More: Company Gains Ultrasound-Linked Drug Capsule Technology A discoverer of neuroscience therapies and a genomics data science company are developing machine learning models to predict clinical trial outcomes for ADHD drugs. . . . → Read More: Biotech, A.I. Companies Model Animal Studies/Clinical Trials A clinical trial has begun testing an experimental treatment for burns using off-the-shelf therapeutic particles derived from human bone marrow stem cells. . . . → Read More: Trial Underway Testing Stem Cell Particles for Burns A developer of electronic health data tools and a university’s neuroscience labs are collaborating on tests of Parkinson’s disease drugs using digital measures of patient functioning. . . . → Read More: Industry, Univ. Labs Partner on Parkinson’s Digital Biomarkers Regeneron Pharmaceuticals, a maker of synthetic biologic treatments, is acquiring Decibel Therapeutics, developer of gene therapies to treat hearing loss and balance disorders. . . . → Read More: Regeneron Acquires Hearing Loss Biotech in $213M Deal A women’s health biotechnology company is partnering with a Brazilian drug maker to evaluate a precision target and treatment for ovarian health disorders. . . . → Read More: Companies to Assess Ovarian Health Biotech Drug |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |